Previously untreated ( treatment-naive ) patients were randomly assigned ( 1:1 ) by computer-generated randomisation lists to receive once-daily ombitasvir ( 25 mg ) plus paritaprevir ( 150 mg ) plus ritonavir ( 100 mg ) with or without weight-based ribavirin for 12 weeks .